Αποτελέσματα Αναζήτησης
22 Ιουλ 2024 · Bain Capital Private Equity pioneered the value-added investment approach. Our globally integrated teams leverage deep vertical expertise and partner with management teams around the world to accelerate growth.
- Portfolio
Portfolio - Bain Capital Private Equity
- Industries
Industries - Bain Capital Private Equity
- Strategy Overview
Strategy Overview - Bain Capital Private Equity
- People
People - Bain Capital Private Equity
- About
About - Bain Capital Private Equity
- Contact
Contact - Bain Capital Private Equity
- Matthias Boyer Chammard
Matthias Boyer Chammard - Bain Capital Private Equity
- Ivano Sessa
Ivano Sessa - Bain Capital Private Equity
- Portfolio
In October 2018, Bain Capital Private Equity and Bain Capital Life Sciences committed $350 million to a new biopharmaceutical company Cerevel Therapeutics. However, only $250 million of the committed amount was drawn.
5 Νοε 2024 · Dividend History. (1) The dividend was adjusted to $0.34 per share as all rights were exercised pursuant to the Company's announced rights offering. The second quarter dividend is payable on July 30, 2020 to holders of record as of June 30, 2020.
Bain Capital Private Equity serves customers worldwide. Company profile page for Bain Capital Private Equity LP including stock price, company news, executives, board members, and...
31 Δεκ 2022 · BOSTON--Bain Capital Specialty Finance, Inc. (NYSE: BCSF, the “Company”, “our” or “we”) today announced financial results for the first quarter ended March 31, 2023, and that its Board of Directors has declared a dividend of $0.38 per share for the second quarter of 2023.
Information on investments, active portfolio, exits, fund performance, and dry powder for Bain Capital. Use the PitchBook Platform to explore the full profile.
Bain Capital, LP is one of the world’s leading multi-asset alternative investment firms. With offices on four continents, our global team aligns our interests with those of our investors and partners for lasting impact.
